RPBio (Korea) Performance
| 314140 Stock | 5,540 210.00 3.94% |
The company owns a Beta (Systematic Risk) of 0.5, which implies possible diversification benefits within a given portfolio. As returns on the market increase, RPBio's returns are expected to increase less than the market. However, during the bear market, the loss of holding RPBio is expected to be smaller as well. At this point, RPBio Inc has a negative expected return of -0.3%. Please make sure to check RPBio's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if RPBio Inc performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days RPBio Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
RPBio |
RPBio Relative Risk vs. Return Landscape
If you would invest 670,000 in RPBio Inc on August 28, 2024 and sell it today you would lose (116,000) from holding RPBio Inc or give up 17.31% of portfolio value over 90 days. RPBio Inc is generating negative expected returns and assumes 2.4839% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than RPBio, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
RPBio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RPBio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as RPBio Inc, and traders can use it to determine the average amount a RPBio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1194
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 314140 |
Estimated Market Risk
| 2.48 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average RPBio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RPBio by adding RPBio to a well-diversified portfolio.
Things to note about RPBio Inc performance evaluation
Checking the ongoing alerts about RPBio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RPBio Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RPBio Inc generated a negative expected return over the last 90 days |
- Analyzing RPBio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RPBio's stock is overvalued or undervalued compared to its peers.
- Examining RPBio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RPBio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RPBio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RPBio's stock. These opinions can provide insight into RPBio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for RPBio Stock analysis
When running RPBio's price analysis, check to measure RPBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RPBio is operating at the current time. Most of RPBio's value examination focuses on studying past and present price action to predict the probability of RPBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RPBio's price. Additionally, you may evaluate how the addition of RPBio to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |